Company
Headquarters: Chesterbrook, PA, United States
Founded: Merger between AmeriSource Health and Bergen Brunswig in 2001
Employees: 38,000
CEO: Mr. Steven H. Collis
$43.82 Billion
USD as of July 1, 2024
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.67 B |
| Cardinal Health, Inc. | $23.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
| Sinopharm Group Co. Ltd | $8.37 B |
| Henry Schein, Inc. | $8.32 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Cencora, Inc. has the following listings and related stock indices.
Stock: NYSE: COR wb_incandescent
Stock: FSX: ABG wb_incandescent
Pharmaceuticals and pharmacy services
Richard C. Gozon (Chairman) Steven H. Collis (President), (CEO) & (Director)
Revenue: US$213.99 billion (2021)
Operating income: US$1.11 billion (2019)
Net income: US$1.54 million (2021)
Total assets: US$39.17 billion (2019)
Total equity: US$2.99 billion (2019)